Browsing by Subject "A61K 38/00"
Now showing items 1-20 of 38
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2009-11-10)A bioinformatic method is provided for identifying and isolating proteins with MSCRAMM®—like characteristics from Gram positive bacteria, such as Enterococcus, Staphylococcus, Streptococcus and Bacillus bacteria, which can ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-12-14)A bioinformatic method is provided for identifying and isolating proteins with MSCRAMM®—like characteristics from Gram positive bacteria, such as Enterococcus, Staphylococcus, Streptococcus and Bacillus bacteria, which can ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-09-11)Disclosed are the cna gene and cna-derived nucleic acid segments from Staphylococcus aureus, and DNA segments encoding cna from related bacteria. Also disclosed are Col binding protein (CBP) compositions and methods of ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-10-02)The present invention provides a method for determining the structure of a microbial surface components recognizing adhesive matrix molecule in complex with fibrinogen, by providing a ClfA complexed with a fibrinogen ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-06-22)The present invention discloses crystal structure of Staphylococcus aureus Clumping factor A (ClfA) in complex with fibrinogen (Fg) derived peptide. Also, the present invention also discloses the use of this structure in ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-04-10)Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-11-06)Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-05-08)Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-06-19)Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-12-29)Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-05-07)A method of selectively modulating the activity of C5a receptor 2 (C5aR2). The method includes exposing the receptor to a compound that selectively modulates C5aR2 compared to C5a receptor 1 (C5aR1). In some cases, the ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2008-06-03)Isolated extracellular matrix-binding proteins, designated ClfB, SdrC, SdrD and SdrE, and their corresponding amino acid and nucleic acid sequences and motifs are described. The proteins, peptides, fragments thereof or ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2004-01-20)Isolated extracellular matrix-binding proteins, designated ClfB, SdrC, SdrD and SdrE, and their corresponding amino acid and nucleic acid sequences and motifs are described. The proteins, peptides, fragments thereof or ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2011-12-06)The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-06-29)The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2004-11-02)The present invention relates to a method and apparatus for isolating anticoagulant heparin or heparan sulfate by binding the anticoagulant heparin or anticoagulant heparan sulfate onto an affinity matrix and separating ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2004-02-03)Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2006-10-31)Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 10/4/2022)The present disclosure includes a fusion protein, called a "Seldeg", including a targeting component that specifically binds to a cell surface receptor or other cell surface molecule at near-neutral pH, and an antigen ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2014-04-29)The present invention compositions and methods of using at least a portions of an isolated and purified α-crystallin polypeptide that includes one or more β-pleated sheets and that prevents neurotoxicity and amyloidogenesis.